Ghent University Academic Bibliography

Advanced

Respiratory hypersensitivity reactions to NSAIDs in Europe : the global allergy and asthma network (GA2LEN) survey

JS Makowska, P Burney, D Jarvis, T Keil, Peter Tomassen, J Bislimovska, G Brozek, Claus Bachert UGent, J Baelum, C Bindslev-Jensen, et al. (2016) ALLERGY. 71(11). p.1603-1611
abstract
Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most prevalent drugs inducing hypersensitivity reactions. The aim of this analysis was to estimate the prevalence of NSAID-induced respiratory symptoms in population across Europe and to assess its association with upper and lower respiratory tract disorders. Methods: The GA(2)LEN survey was conducted in 22 centers in 15 European countries. Each of 19 centers selected random samples of 5000 adults aged 15-74 from their general population, and in three centers (Athens, Munich, Oslo), a younger population was sampled. Questionnaires including questions about age, gender, presence of symptoms of asthma, allergic rhinitis, chronic rhinosinusitis, smoking status, and history of NSAID-induced hypersensitivity reactions were sent to participants by mail. Totally, 62 737 participants completed the questionnaires. Results: The mean prevalence of NSAID-induced dyspnea was 1.9% and was highest in the three Polish centers [Katowice (4.9%), Krakow (4.8%), and Lodz (4.4%)] and lowest in Skopje, (0.9%), Amsterdam (1.1%), and Umea (1.2%). In multivariate analysis, the prevalence of respiratory reactions to NSAIDs was higher in participants with chronic rhinosinusitis symptoms (Odds Ratio 2.12; 95%CI 1.78-2.74), asthma symptoms in last 12 months (2.7; 2.18-3.35), hospitalization due to asthma (1.53; 1.22-1.99), and adults vs children (1.53; 1.24-1.89), but was not associated with allergic rhinitis. Conclusion: Our study documented significant variation between European countries in the prevalence of NSAID-induced respiratory hypersensitivity reactions, and association with chronic airway diseases, but also with environmental factors.
Please use this url to cite or link to this publication:
author
year
type
journalArticle (original)
publication status
published
subject
keyword
drug allergy, epidemiology, GA2LEN, NSAIDs hypersensitivity, NONSTEROIDAL ANTIINFLAMMATORY DRUGS, ASPIRIN-INTOLERANT ASTHMA, QUESTIONNAIRE SURVEY, PROVOCATION TESTS, NASAL POLYPOSIS, NATURAL-HISTORY, PREVALENCE, POPULATION, DISEASE, CLASSIFICATION
journal title
ALLERGY
Allergy
volume
71
issue
11
pages
1603 - 1611
Web of Science type
Article
Web of Science id
000386083700010
JCR category
ALLERGY
JCR impact factor
7.361 (2016)
JCR rank
2/26 (2016)
JCR quartile
1 (2016)
ISSN
0105-4538
DOI
10.1111/all.12941
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
8502451
handle
http://hdl.handle.net/1854/LU-8502451
date created
2017-01-17 08:17:05
date last changed
2017-03-21 10:26:37
@article{8502451,
  abstract     = {Background: Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most prevalent drugs inducing hypersensitivity reactions. The aim of this analysis was to estimate the prevalence of NSAID-induced respiratory symptoms in population across Europe and to assess its association with upper and lower respiratory tract disorders. 
Methods: The GA(2)LEN survey was conducted in 22 centers in 15 European countries. Each of 19 centers selected random samples of 5000 adults aged 15-74 from their general population, and in three centers (Athens, Munich, Oslo), a younger population was sampled. Questionnaires including questions about age, gender, presence of symptoms of asthma, allergic rhinitis, chronic rhinosinusitis, smoking status, and history of NSAID-induced hypersensitivity reactions were sent to participants by mail. Totally, 62 737 participants completed the questionnaires. 
Results: The mean prevalence of NSAID-induced dyspnea was 1.9\% and was highest in the three Polish centers [Katowice (4.9\%), Krakow (4.8\%), and Lodz (4.4\%)] and lowest in Skopje, (0.9\%), Amsterdam (1.1\%), and Umea (1.2\%). In multivariate analysis, the prevalence of respiratory reactions to NSAIDs was higher in participants with chronic rhinosinusitis symptoms (Odds Ratio 2.12; 95\%CI 1.78-2.74), asthma symptoms in last 12 months (2.7; 2.18-3.35), hospitalization due to asthma (1.53; 1.22-1.99), and adults vs children (1.53; 1.24-1.89), but was not associated with allergic rhinitis. 
Conclusion: Our study documented significant variation between European countries in the prevalence of NSAID-induced respiratory hypersensitivity reactions, and association with chronic airway diseases, but also with environmental factors.},
  author       = {Makowska, JS and Burney, P and Jarvis, D and Keil, T and Tomassen, Peter and Bislimovska, J and Brozek, G and Bachert, Claus and Baelum, J and Bindslev-Jensen, C and Bousquet, J and Bousquet, PJ and Kai-H{\aa}kon, C and Dahlen, SE and Dahlen, B and Fokkens, WJ and Forsberg, B and Gjomarkaj, M and Howarth, P and Salagean, E and Janson, C and Kasper, L and Kraemer, U and Louiro, C and Lundback, B and Minov, J and Nizankowska-Mogilnicka, E and Papadopoulos, N and Sakellariou, AG and Todo-Bom, A and Toskala, E and Zejda, JE and Zuberbier, T and Kowalski, ML},
  issn         = {0105-4538},
  journal      = {ALLERGY},
  keyword      = {drug allergy,epidemiology,GA2LEN,NSAIDs hypersensitivity,NONSTEROIDAL ANTIINFLAMMATORY DRUGS,ASPIRIN-INTOLERANT ASTHMA,QUESTIONNAIRE SURVEY,PROVOCATION TESTS,NASAL POLYPOSIS,NATURAL-HISTORY,PREVALENCE,POPULATION,DISEASE,CLASSIFICATION},
  language     = {eng},
  number       = {11},
  pages        = {1603--1611},
  title        = {Respiratory hypersensitivity reactions to NSAIDs in Europe : the global allergy and asthma network (GA2LEN) survey},
  url          = {http://dx.doi.org/10.1111/all.12941},
  volume       = {71},
  year         = {2016},
}

Chicago
Makowska, JS, P Burney, D Jarvis, T Keil, PETER TOMASSEN, J Bislimovska, G Brozek, et al. 2016. “Respiratory Hypersensitivity Reactions to NSAIDs in Europe : the Global Allergy and Asthma Network (GA2LEN) Survey.” Allergy 71 (11): 1603–1611.
APA
Makowska, J., Burney, P., Jarvis, D., Keil, T., TOMASSEN, P., Bislimovska, J., Brozek, G., et al. (2016). Respiratory hypersensitivity reactions to NSAIDs in Europe : the global allergy and asthma network (GA2LEN) survey. ALLERGY, 71(11), 1603–1611.
Vancouver
1.
Makowska J, Burney P, Jarvis D, Keil T, TOMASSEN P, Bislimovska J, et al. Respiratory hypersensitivity reactions to NSAIDs in Europe : the global allergy and asthma network (GA2LEN) survey. ALLERGY. 2016;71(11):1603–11.
MLA
Makowska, JS, P Burney, D Jarvis, et al. “Respiratory Hypersensitivity Reactions to NSAIDs in Europe : the Global Allergy and Asthma Network (GA2LEN) Survey.” ALLERGY 71.11 (2016): 1603–1611. Print.